Kinji Shirota
- Molecular Biology
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Epidemiology
- Co-authors
- Serge JothySarita BenchimolAbraham FuksNicole BeaucheminClifford P. StannersSongyang YuanLam LeduyYasuo Nomura
- Topics
- Veterinary Oncology Research (18 papers)Renal Diseases and Glomerulopathies (17 papers)Chronic Kidney Disease and Diabetes (13 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Kinji Shirota
108 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 581
- Oncology 399
- Radiology, Nuclear Medicine and Imaging 354
- Immunology 280
- Epidemiology 246
Countries citing papers authored by Kinji Shirota
This map shows the geographic impact of Kinji Shirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kinji Shirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kinji Shirota more than expected).
Fields of papers citing papers by Kinji Shirota
This network shows the impact of papers produced by Kinji Shirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kinji Shirota. The network helps show where Kinji Shirota may publish in the future.
Co-authorship network of co-authors of Kinji Shirota
This figure shows the co-authorship network connecting the top 25 collaborators of Kinji Shirota. A scholar is included among the top collaborators of Kinji Shirota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kinji Shirota. Kinji Shirota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | Clinical and pathological findings of an outbreak of Tyzzer’s disease in a rabbit colony in Croatia | 1 |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 26 | |
| 12 | 4 | |
| 13 | 23 | |
| 14 | 20 | |
| 15 | 19 | |
| 16 | 48 | |
| 17 | 129 | |
| 18 | 68 | |
| 19 | Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion moleculebreakdown → | 808 |
| 20 | 2 |
About Kinji Shirota
Kinji Shirota is a scholar working on Nephrology, Small Animals and Dermatology, having authored 112 papers that have together received 1.8k indexed citations. Recurring topics across this work include Veterinary Oncology Research (18 papers), Renal Diseases and Glomerulopathies (17 papers) and Chronic Kidney Disease and Diabetes (13 papers). The work is most often cited by research in Immunology and Allergy (168 citations), Radiology, Nuclear Medicine and Imaging (354 citations) and Oncology (399 citations). Kinji Shirota has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Serge Jothy, Sarita Benchimol, Abraham Fuks, Nicole Beauchemin, Clifford P. Stanners, Songyang Yuan, Lam Leduy, Yasuo Nomura, Junichi Kamiie and Mariko Shirota. Their work appears in journals such as Cell, Biochemical and Biophysical Research Communications and Chemosphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.